Dallas, Texas (PRWEB) November 13, 2014
The Global Defibrillator Market 2014-2018 report says one of the major trends upcoming in the Defibrillator market is the growing use of multifunction defibrillators. The most important driver of the cardiovascular devices market is increased incidence of cardiac disorders. It is used to deliver a therapeutic dose of electrical energy in the form of electric shocks to the heart muscle for restoring normal heart rhythms.
The analysts forecast the Global Defibrillator market to grow at a CAGR of 6.27 percent over the period 2013-2018.
This Global Defibrillator Market 2014-2018 report covers the present scenario and the growth prospects of the Global Defibrillator market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of the following types of products: Automated external defibrillators (AEDs), Implantable cardioverter defibrillator (ICDs), advanced life support defibrillators and Wearable defibrillators.
The major end-users of the defibrillators are hospitals, individuals, emergency medical services providers, and businesses.
The Global Defibrillator Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Defibrillator market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Order a copy of this report at (Prices start at US $2500 for a single user PDF) http://www.sandlerresearch.org/purchase?rname=27365.
The report profiles key vendors like BIOTRONIK, Boston Scientific, Medtronic, Phillips Healthcare and St. Jude Medical.
Other Prominent Vendors are Asahi Kasei, Defibtech, Exactech, GE Healthcare, Heartsine Technologies, Mindray Medical International, Nihon Kohden, Physio-Control, Schiller, Sorin
Further, the report states that one of the major challenges confronting the market is the safety concerns associated with defibrillators.
Other Related Reports on Medical Device Market:
Global Cardiac Biomarkers Market 2014-2018: Analysts forecast the Global Cardiac Biomarkers market to grow at a CAGR of 12.75 percent over the period 2013-2018.
The key players profiled Abbott Laboratories, Alere Inc., Ortho Clinical Diagnostics Inc. and Roche Diagnostics.
Other Prominent Vendors in the market are: AniBiotech, Axis-Shield, Beckman Coulter, Becton, Dickinson & Co., BG Medicine, bioMérieux, Boston Scientific, Critical Diagnostics, diaDexus, LifeSign, Mitsubishi Chemical Europe, Nanomix, Radiometer Medical, Randox Laboratories, Response Biomedical, Siemens Healthcare, Sierra Resources International, Singulex, Thermo Scientific and Trinity Biotech.
Global Heart Valve Repair and Replacement Market 2014-2018: Analysts forecast the Global Heart Valve Repair and Replacement market to grow at a CAGR of 7.72 percent over the period 2013-2018.
One of the emerging trends in the market is the increase in the number of products approved by regulatory authorities such as the FDA and CE. Such products are considered to be safe for commercial use increasing their adoption rate.
The key players profiled are Abbott Laboratories, Edwards Lifesciences Corp., Medtronic Inc. and St. Jude Medical Inc.
Other Prominent Vendors in the market are: AorTech, Boston Scientific, Colibri Heart Valve, CryoLife , Direct Flow Medical, JenaValve, MiCardia, Mitralign , Neovasc, On-X Life Technologies, Sorin , Symentis and ValveXchange
Global Heart Defect Closure Devices Market 2014-2018: Analysts forecast the Global Heart Defect Closure Devices market will grow at a CAGR of 9 percent over the period 2013-2018.
According to the report, the Global Heart Defect Closure Devices market is driven by several factors, of which an increase in the incidence of CHDs among the pediatric population worldwide is one of the major drivers. This has led to an increase in demand for heart defect closure devices for the treatment of CHDs such as ASD, VSD, PFO, PDA, and LAA. Other major factors contributing to the demand for heart defect closure devices are high adoption of MRI procedures and increasing use of chemotherapy.
The report recognizes the following companies as the key players in the Global Heart Defect Closure Devices Market: Boston Scientific Corp., St. Jude Medical Inc., W.L. Gore and Associates Inc.Other Prominent Vendors, Biosense Webster, Cardia Inc. , LifeTech Scientific , Maquet Cardiovascular, Medtronic , Occlutech Holding AG, Pfm medical, Starway Medical Technology ,Terumo Cardiovascula
Sandlerresearch.org is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.